← Latest Filings
C
Coloma Jason V
Chief Executive Officer
Open-market buys
0
$0 total
Open-market sells
23
$5.4M total
Tracking since
May 2026
Activity timeline
Open-market sale — $166K
Maze Therapeutics, Inc. · Nov 2, 2026
Open-market sale — $799K
Maze Therapeutics, Inc. · Nov 2, 2026
Open-market trades from the last two years.
Holdings as last reported
913,242 Common Stock in BRVE
Held indirectly (By Westport Meridian Capital LP) · as of 2026-08-05
186,901 Common Stock in MAZE
Held indirectly (Coloma Family Trust) · as of 2026-11-02
Companies touched
Maze Therapeutics, Inc.
CIK 0001842295
Braveheart Bio, Inc.
CIK 0002131524
